Previous close | 0.5000 |
Open | 1.1000 |
Bid | 0.0500 |
Ask | 0.7000 |
Strike | 390.00 |
Expiry date | 2024-07-19 |
Day's range | 0.5000 - 1.1000 |
Contract range | N/A |
Volume | |
Open interest | 25 |
Charles River (CRL) announces the development of non-clinical VCG with Sanofi to reduce the use of animals in research.
WILMINGTON, Mass., June 11, 2024--Charles River announces an integrated program, funded by a $1.3 million grant, to develop an in vitro alternative to inhalation toxicology studies
WILMINGTON, Mass., June 06, 2024--Charles River announces the opening of a new CRADL® facility on Chestnut Street in Somerville, Massachusetts, an emerging life sciences hub.